Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1291

  • Showing results for liang cheng. Search instead for Lifang Sheng (2 items)
1.

A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer.

Ventimiglia E, Seisen T, Abdollah F, Briganti A, Fonteyne V, James N, Roach M 3rd, Thalmann GN, Touijer K, Chen RC, Cheng L.

Eur Urol Oncol. 2019 May;2(3):294-301. doi: 10.1016/j.euo.2019.02.001. Epub 2019 Mar 23. Review.

PMID:
31200844
2.

MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia.

Magers MJ, Iczkowski KA, Montironi R, Grignon DJ, Zhang S, Williamson SR, Yang X, Wang M, Osunkoya AO, Lopez-Beltran A, Hes O, Eble JN, Cheng L.

Mod Pathol. 2019 Jun 12. doi: 10.1038/s41379-019-0297-6. [Epub ahead of print]

PMID:
31189999
3.

LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling.

Luo J, Wang K, Yeh S, Sun Y, Liang L, Xiao Y, Xu W, Niu Y, Cheng L, Maity SN, Jiang R, Chang C.

Nat Commun. 2019 Jun 12;10(1):2571. doi: 10.1038/s41467-019-09784-9.

PMID:
31189930
4.

Re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019;75:667-75: How Does Circulating DNA Reach the Blood Stream?

Montironi R, Cheng L, Scarpelli M, Cimadamore A, Montorsi F, Lopez-Beltran A.

Eur Urol. 2019 Jun 5. pii: S0302-2838(19)30442-7. doi: 10.1016/j.eururo.2019.05.035. [Epub ahead of print] No abstract available.

PMID:
31176624
5.

Association of OSAHS Hypoxia Indicators with Early Renal Injury and Serum Fibroblast Growth Factor 21 in Obese Type 2 Diabetic Patients.

Yu W, Wang X, Ni Y, Huai, Hao H, Li Q, Liu Z, Wen S, Cheng L, Hu W.

Diabetes Ther. 2019 Jun 6. doi: 10.1007/s13300-019-0639-x. [Epub ahead of print]

PMID:
31172456
6.

Integrative analysis of pathological images and multi-dimensional genomic data for early-stage cancer prognosis.

Shao W, Han Z, Cheng J, Cheng L, Wang T, Sun L, Lu Z, Zhang J, Zhang D, Huang K.

IEEE Trans Med Imaging. 2019 Jun 3. doi: 10.1109/TMI.2019.2920608. [Epub ahead of print]

PMID:
31170067
7.

Mesoporous gold nanoparticles for photothermal controlled anticancer drug delivery.

Zhang L, Shen S, Cheng L, You H, Lu L, Ma C, Dai Y, Fang J.

Nanomedicine (Lond). 2019 Jun 6. doi: 10.2217/nnm-2018-0242. [Epub ahead of print]

PMID:
31169451
8.

Clinicopathological characteristics of ypT0N0 urothelial carcinoma following neoadjuvant chemotherapy and cystectomy.

Magers MJ, Kaimakliotis HZ, Barboza MP, Bandali E, Adra N, Koch MO, Cheng L.

J Clin Pathol. 2019 Jun 4. pii: jclinpath-2019-205742. doi: 10.1136/jclinpath-2019-205742. [Epub ahead of print]

PMID:
31164444
9.

Identification of Cancer Dysfunctional Subpathways by Integrating DNA Methylation, Copy Number Variation, and Gene-Expression Data.

Liu S, Zheng B, Sheng Y, Kong Q, Jiang Y, Yang Y, Han X, Cheng L, Zhang Y, Han J.

Front Genet. 2019 May 15;10:441. doi: 10.3389/fgene.2019.00441. eCollection 2019.

10.

Association between tea consumption and risk of cancer: a prospective cohort study of 0.5 million Chinese adults.

Li X, Yu C, Guo Y, Bian Z, Shen Z, Yang L, Chen Y, Wei Y, Zhang H, Qiu Z, Chen J, Chen F, Chen Z, Lv J, Li L; China Kadoorie Biobank Collaborative Group.

Eur J Epidemiol. 2019 May 31. doi: 10.1007/s10654-019-00530-5. [Epub ahead of print]

PMID:
31152367
11.

Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study.

Al-Obaidy KI, Eble JN, Cheng L, Williamson SR, Sakr WA, Gupta N, Idrees MT, Grignon DJ.

Am J Surg Pathol. 2019 May 22. doi: 10.1097/PAS.0000000000001288. [Epub ahead of print]

PMID:
31135486
12.

Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung.

He SY, Xi WJ, Wang X, Xu CH, Cheng L, Liu SY, Meng QQ, Li B, Wang Y, Shi HB, Wang HJ, Wang ZZ.

Med Sci Monit. 2019 May 27;25:3941-3956. doi: 10.12659/MSM.913727.

13.

Distinct Mutational Landscape of Inverted Urothelial Papilloma.

Akgul M, MacLennan GT, Cheng L.

J Pathol. 2019 May 22. doi: 10.1002/path.5307. [Epub ahead of print]

PMID:
31119740
14.

Cancer incidence in relation to body fatness among 0.5 million men and women: Findings from the China Kadoorie Biobank.

Wang L, Jin G, Yu C, Lv J, Guo Y, Bian Z, Yang L, Chen Y, Hu Z, Chen F, Chen Z, Li L, Shen H; China Kadoorie Biobank Collaborative Group.

Int J Cancer. 2019 May 22. doi: 10.1002/ijc.32394. [Epub ahead of print]

PMID:
31115907
15.

Editorial: Emerging Biomarkers in Genitourinary Tumors.

Montironi R, Santoni M, Cimadamore A, Lopez-Beltran A, Cheng L.

Front Oncol. 2019 Apr 26;9:326. doi: 10.3389/fonc.2019.00326. eCollection 2019. No abstract available.

16.

Early Cancer Detection from Multianalyte Blood Test Results.

Wong KC, Chen J, Zhang J, Lin J, Yan S, Zhang S, Li X, Liang C, Peng C, Lin Q, Kwong S, Yu J.

iScience. 2019 May 31;15:332-341. doi: 10.1016/j.isci.2019.04.035. Epub 2019 May 4.

17.

Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.

Wei Y, Gu X, Cheng L, Meng F, Storm G, Zhong Z.

Acta Biomater. 2019 Jul 1;92:196-204. doi: 10.1016/j.actbio.2019.05.034. Epub 2019 May 15.

PMID:
31102765
18.

Dysbiosis of the Gut Microbiome in Lung Cancer.

Zhuang H, Cheng L, Wang Y, Zhang YK, Zhao MF, Liang GD, Zhang MC, Li YG, Zhao JB, Gao YN, Zhou YJ, Liu SL.

Front Cell Infect Microbiol. 2019 Apr 18;9:112. doi: 10.3389/fcimb.2019.00112. eCollection 2019.

19.

Plasmacytoid/diffuse urothelial carcinoma: a single institution immunohistochemical and molecular study of 69 patients.

Perrino CM, Eble J, Kao CS, Whaley RD, Cheng L, Idrees M, Hashemi-Sadraei N, Monn MF, Kaimakliotis HZ, Bandali E, Grignon D.

Hum Pathol. 2019 May 2. pii: S0046-8177(19)30077-2. doi: 10.1016/j.humpath.2019.04.012. [Epub ahead of print]

PMID:
31054897
20.

Correlation of Gut Microbiome Between ASD Children and Mothers and Potential Biomarkers for Risk Assessment.

Li N, Yang J, Zhang J, Liang C, Wang Y, Chen B, Zhao C, Wang J, Zhang G, Zhao D, Liu Y, Zhang L, Yang J, Li G, Gai Z, Zhang L, Zhao G.

Genomics Proteomics Bioinformatics. 2019 Feb;17(1):26-38. doi: 10.1016/j.gpb.2019.01.002. Epub 2019 Apr 23.

Supplemental Content

Loading ...
Support Center